We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to register your medical devices with the MHRA for the markets in Great Britain and Northern Ireland.
How to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
Information relating to good clinical practice (GCP) inspections.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Information on telecare monitoring systems and personal alarms that can help you stay safe and independent at home.
MHRA guidance on the use of non-clinical data generated outside the OECD MAD framework in support of UK Clinical Trial Authorisation applications.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
How to contact the MHRA for specific services or enquiries.
Information about the reproductive risks of taking valproate medicines and the measures in place to reduce potential harm.
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
How to use the procedure for medicines licensing applications.
How to help patients and their families reduce the risks of harm from opioid medicines.
Guidance on the various types of modifications that can be made to a clinical trial approval.
A guide to the legislation enabling drug services and others to supply take home naloxone without a prescription to save a life in an emergency.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
A new MHRA service being developed to help organisations working on novel medicines technologies consider Good Practice requirements earlier.
An overview of the process to get a marketing authorisation (MA), including submitting, fast-tracking an application, naming your medicine and paying fees.
Details of the system for reporting adverse drug reactions from medicines or adverse incidents with medical devices in the UK
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).